Home / Ifosfamide / United States
US ATC L01AA06 · updated 2 Nov 2026
Ifosfamide shortage in United States
Is there an Ifosfamide shortage in United States?
Yes. As of 2 Nov 2026, 8 Ifosfamide products are reported short in United States, the first since 12 Jun 2026. No return date has been given. Main reason: not stated.
Also short in Germany, France, Italy, Austria, Belgium, Switzerland, Czechia, Norway, Sweden, Japan, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02) | SteriMax, Inc. | 12 Jun 2026 | not given | Not stated |
| US | Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10) limited | Fresenius Kabi USA, LLC | 12 Jun 2026 | not given | Increased demand Demand increase for the drug |
| US | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01) | Hikma Pharmaceuticals USA, Inc. | 12 Jun 2026 | not given | Increased demand Demand increase for the drug |
| US | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01) | Hikma Pharmaceuticals USA, Inc. | 12 Jun 2026 | not given | Increased demand Demand increase for the drug |
| US | IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01) | Baxter Healthcare | 12 Jun 2026 | not given | Not stated |
| US | IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) | Baxter Healthcare | 12 Jun 2026 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| US | Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01) | Baxter Healthcare | 12 Jun 2026 | not given | Not stated |
| US | Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02) | Baxter Healthcare | 12 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).